Pharmaniaga Berhad
7081.KL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.02B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.02 Billion |
|---|---|
| Enterprise Value | $1.37 Billion |
| Annual dividend | $0.02 |
| Dividend yield | 2.23% |
| Earnings per Share | $0.07 |
| Beta | 0.77 |
| Outstanding Shares | 1,311,405,000 |
Return
| Return on Equity | 16.31% |
|---|---|
| Return on Assets | 3.20% |
| Return on Invested Capital | 15.35% |
Valuation & Multiples
| P/E Ratio | 12.11 |
|---|---|
| PEG | 4.64 |
| Price to Sales | 0.26 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.33 |
| Enterprise Value to EBIT | 10.47 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 1 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 13, 2026
EPS
$0.02
ReportedRevenue
$1.01 B
ReportedNext Earnings Call
Expected Date
March 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Pharmaniaga Berhad
3,538 employees
CEO: Zulkifli Bin Jafar
Pharmaniaga Berhad operates as an investment holding company and an integrated pharmaceutical entity across Malaysia, Indonesia, and international territories. The company organizes its operations into three main segments: Logistics and ...